Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis

被引：0
|
作者：
Baniasadi, Shadi [1 ]
Fahimi, Fanak [2 ]
Tabarsi, Payam [2 ]
Nadji, Seyed Alireza [1 ]
Khabiri, Shadi [2 ]
Shahsavari, Nahid [3 ]
Kobarfard, Farzad [3 ]
机构：
[1] Natonal Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran
[2] Natonal Res Inst TB & Lung Dis, Chron Resp Dis Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Med Chem Dept, Sch Pharm, Tehran, Iran
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Pharmacology; Infections; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2959
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children
    Mukherjee, A.
    Velpandian, T.
    Singla, M.
    Kanhiya, K.
    Kabra, S. K.
    Lodha, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 666 - 672
  • [22] PREVALENCE OF TUBERCULOSIS AND THE USE OF ISONIAZID PROPHYLAXIS IN ANERGIC HIV-INFECTED PATIENTS
    BARRIO, E
    CARBALLO, E
    CABARCOS, A
    AIDS, 1994, 8 (06) : 857 - 858
  • [23] Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: Is it different than in HIV-uninfected persons?
    Gordin, FM
    Cohn, DL
    Matts, JP
    Chaisson, RE
    O'Brien, RJ
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 561 - 565
  • [24] The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
    Akos Somoskovi
    Linda M Parsons
    Max Salfinger
    Respiratory Research, 2
  • [25] Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors
    Beauverie, P
    Taburet, AM
    Dessalles, MC
    Furlan, V
    Touzeau, D
    AIDS, 1998, 12 (18) : 2510 - 2511
  • [26] The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
    Somoskovi, A
    Parsons, LM
    Salfinger, M
    RESPIRATORY RESEARCH, 2001, 2 (03) : 164 - 168
  • [27] DRUG MALABSORPTION AND RESISTANT TUBERCULOSIS IN HIV-INFECTED PATIENTS
    PATEL, KB
    BELMONTE, R
    CROWE, HM
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05): : 336 - 337
  • [28] Intestinal Barrier Function and Serum Concentrations of Rifampin, Isoniazid and Pyrazinamide in Patients with Pulmonary Tuberculosis
    Facanha, Monica C.
    Gondim, Argina M. B.
    Pinheiro, Valeria G. F.
    Barroso, Elizabeth C.
    Peloquin, Charles A.
    Guerrant, Richard L.
    Lima, Aldo A. M.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03): : 210 - 217
  • [29] The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis
    Perlman, DC
    Segal, Y
    Rosenkranz, S
    Rainey, PM
    Remmel, RP
    Salomon, N
    Hafner, R
    Peloquin, CA
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) : 1638 - 1647
  • [30] Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis
    Gourevitch, MN
    Hartel, D
    Selwyn, PA
    Schoenbaum, EE
    Klein, RS
    AIDS, 1999, 13 (15) : 2069 - 2074
12345